EU Health Minister Harsh Vardhan said Thursday that the coronavirus vaccine would be available in the country earlier next year, at a time when India is seeing more than 50 cases of lakh and others are waiting for the vaccine to be applied. a respite.
“Like other countries, India is also making efforts. Three candidate vaccines are in other phases. Under the leadership of the Prime Minister, a panel of experts is examining the factor and complex plans have been put in place. We hope that until early next year,” there will be a vaccine in India,” Harsh Vardhan told Rajya Sabha.
Two vaccines from Zydus Cadila and Bharat Biotech have completed phase 1. Serum Institute of India (SII) has re-tested after obtaining authorization from the Comptroller General of Drugs of India.
India is the producer wife of the candidate vaccine called Covishield, jointly developed through the Jenner Institute of the University of Oxford and AstraZeneca. The SII company, based in Pune, is achieving results at 17 control sites across India.
In addition, the Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories Limited, a global pharmaceutical company in India, agreed to cooperate in clinical trials and distribution of the Sputnik V vaccine in India.
Sputnik V, an adenovirus-based vaccine, evolved through the Gamaleya Institute for Scientific Research in Epidemiology and Microbiology, with the Russian Direct Investment Fund and registered on August 11.
“With regulatory approval in India, RDIF will supply Dr. Reddy with one hundred million doses of the vaccine. The Sputnik V vaccine, which is based on a well-studied and proven human adenoviral vector platform, is being clinical trials for the coronavirus pandemic,” said one member of the fund.
For all the latest news from India, the Indian section.